<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35341747</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1090-2430</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>352</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Experimental neurology</Title>
          <ISOAbbreviation>Exp Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mycobacterium leprae induces Schwann cell proliferation and migration in a denervated milieu following intracutaneous excision axotomy in nine-banded armadillos.</ArticleTitle>
        <Pagination>
          <StartPage>114053</StartPage>
          <MedlinePgn>114053</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.expneurol.2022.114053</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0014-4886(22)00078-4</ELocationID>
        <Abstract>
          <AbstractText>Nine-banded armadillos develop peripheral neuropathy after experimental Mycobacterium leprae infection that recapitulates human disease. We used an intracutaneous excision axotomy model to assess the effect of infection duration by M. leprae on axonal sprouting and Schwan cell density. 34 armadillos (17 naïve and 17 M. leprae-infected) underwent 3 mm skin biopsies to create an intracutaneous excision axotomy followed by a concentric 4-mm overlapping biopsy 3 and 12-months post M. leprae inoculation. A traditional distal leg biopsy was obtained at 15mo for intraepidermal nerve fiber (IENF) density. Serial skin sections were immunostained against a axons (PGP9.5, GAP43), and Schwann cells (p75, s100) to visualize regenerating nerves. Regenerative axons and proliferation of Schwann cells was measured and the rate of growth at each time point was assessed. Increasing anti-PGL antibody titers and intraneural M. leprae confirmed infection. 15mo following infection, there was evidence of axon loss with reduced distal leg IENF versus naïve armadillos, p &lt; 0.05. This was associated with an increase in Schwann cell density (11,062 ± 2905 vs. 7561 ± 2715 cells/mm<sup>3</sup>, p &lt; 0.01). Following excisional biopsy epidermal reinnervation increased monotonically at 30, 60 and 90 days; the regeneration rate was highest at 30 days, and decreased at 60 and 90 days. The reinnervation rate was highest among animals infected for 3mo vs those infected for 12mo or naïve animals (mean ± SD, 27.8 ± 7.2 vs.16.2 ± 5.8vs. 15.3 ± 6.5 mm/mm<sup>3</sup>, p &lt; 0.05). The infected armadillos displayed a sustained Schwann cell proliferation across axotomy time points and duration of infection (3mo:182 ± 26, 12mo: 256 ± 126, naive: 139 ± 49 cells/day, p &lt; 0.05). M. leprae infection is associated with sustained Schwann cell proliferation and distal limb nerve fiber loss. Rates of epidermal reinnervation were highest 3mo after infection and normalized by 12 mo of infection. We postulate that excess Schwann cell proliferation is the main pathogenic process and is deleterious to sensory axons. There is a compensatory initial increase in regeneration rates that may be an attempt to compensate for the injury, but it is not sustained and eventually followed by axon loss. Aberrant Schwann cell proliferation may be a novel therapeutic target to interrupt the pathogenic cascade of M. leprae.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ebenezer</LastName>
            <ForeName>Gigi J</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA. Electronic address: gebenezer@jhmi.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pena</LastName>
            <ForeName>Maria T</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>DHHS/HRSA/HSB/National Hansen's Disease Program, Baton Rouge, LA 70816, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daniel</LastName>
            <ForeName>Amrita S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Truman</LastName>
            <ForeName>Richard W</ForeName>
            <Initials>RW</Initials>
            <AffiliationInfo>
              <Affiliation>DHHS/HRSA/HSB/National Hansen's Disease Program, Baton Rouge, LA 70816, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adams</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>DHHS/HRSA/HSB/National Hansen's Disease Program, Baton Rouge, LA 70816, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duthie</LastName>
            <ForeName>Malcolm S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>HDT Bio, Seattle, WA 98102, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wagner</LastName>
            <ForeName>Kelly</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zampino</LastName>
            <ForeName>Serena</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tolf</LastName>
            <ForeName>Eleanor</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsottles</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Polydefkis</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>AAI21005000</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Exp Neurol</MedlineTA>
        <NlmUniqueID>0370712</NlmUniqueID>
        <ISSNLinking>0014-4886</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001135" MajorTopicYN="N">Armadillos</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019771" MajorTopicYN="N">Axotomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007918" MajorTopicYN="Y">Leprosy</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009166" MajorTopicYN="Y">Mycobacterium leprae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Armadillos</Keyword>
        <Keyword MajorTopicYN="Y">Axotomy</Keyword>
        <Keyword MajorTopicYN="Y">Epidermal nerve</Keyword>
        <Keyword MajorTopicYN="Y">Mycobacterium leprae</Keyword>
        <Keyword MajorTopicYN="Y">Regeneration</Keyword>
        <Keyword MajorTopicYN="Y">Schwann cells</Keyword>
        <Keyword MajorTopicYN="Y">Skin</Keyword>
        <Keyword MajorTopicYN="Y">p75</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of competing interests. The authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>28</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35341747</ArticleId>
        <ArticleId IdType="mid">NIHMS1794322</ArticleId>
        <ArticleId IdType="pmc">PMC9019856</ArticleId>
        <ArticleId IdType="doi">10.1016/j.expneurol.2022.114053</ArticleId>
        <ArticleId IdType="pii">S0014-4886(22)00078-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Aarao TLS, de Sousa JR, Falcao ASC, Falcao LFM, Quaresma JAS, 2018. Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update. Front Immunol
9, 939.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5949531</ArticleId>
            <ArticleId IdType="pubmed">29867937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anton ES, Weskamp G, Reichardt LF, Matthew WD, 1994. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proceedings of the National Academy of Sciences of the United States of America
91, 2795–2799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC43457</ArticleId>
            <ArticleId IdType="pubmed">8146193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antunes SLG, Jardim MR, Vital RT, Pascarelli BMO, Nery J, Amadeu TP, Sales AM, da Costa EAF, Sarno EN, 2019. Fibrosis: a distinguishing feature in the pathology of neural leprosy. Memorias do Instituto Oswaldo Cruz
114, e190056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6684007</ArticleId>
            <ArticleId IdType="pubmed">31389520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ard MD, Bunge RP, Bunge MB, 1987. Comparison of the Schwann cell surface and Schwann cell extracellular matrix as promoters of neurite growth. Journal of neurocytology
16, 539–555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3681353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, Banerjee A, Woodhoo A, Jenkins B, Rahman M, Turmaine M, Wicher GK, Mitter R, Greensmith L, Behrens A, Raivich G, Mirsky R, Jessen KR, 2012. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron
75, 633–647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3657176</ArticleId>
            <ArticleId IdType="pubmed">22920255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balagon MV, Gelber RH, Abalos RM, Cellona RV, 2010. Reactions following completion of 1 and 2 year multidrug therapy (MDT). Am J Trop Med Hyg
83, 637–644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2929063</ArticleId>
            <ArticleId IdType="pubmed">20810832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bentley CA, Lee KF, 2000. p75 is important for axon growth and schwann cell migration during development. J Neurosci
20, 7706–7715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6772891</ArticleId>
            <ArticleId IdType="pubmed">11027232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blok DJ, De Vlas SJ, Richardus JH, 2015. Global elimination of leprosy by 2020: are we on track?
Parasites &amp; vectors
8, 548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4618543</ArticleId>
            <ArticleId IdType="pubmed">26490878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, van der Ploeg-van Schip JJ, Abebe M, Hussein J, Khadge S, Neupane KD, Hagge DA, Jordanova ES, Aseffa A, Ottenhoff TH, Geluk A, 2014. T-cell regulation in lepromatous leprosy. PLoS Negl Trop Dis
8, e2773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3983090</ArticleId>
            <ArticleId IdType="pubmed">24722473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brand PW, 1959. Temperature variation and leprosy deformity. Int J Lepr
27, 1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13672668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunge RP, Bunge MB, Eldridge CF, 1986. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annual review of neuroscience
9, 305–328.</Citation>
        </Reference>
        <Reference>
          <Citation>Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman E, Pemmaraju VRR, Gillini L, leprosy, W.H.O.s.n.o.a.r.i., 2018. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15. Clin Microbiol Infect
24, 1305–1310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6286419</ArticleId>
            <ArticleId IdType="pubmed">29496597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YY, McDonald D, Cheng C, Magnowski B, Durand J, Zochodne DW, 2005. Axon and Schwann cell partnership during nerve regrowth. Journal of neuropathology and experimental neurology
64, 613–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16042313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chernousov MA, Stahl RC, Carey DJ, 2001. Schwann cell type V collagen inhibits axonal outgrowth and promotes Schwann cell migration via distinct adhesive activities of the collagen and noncollagen domains. J Neurosci
21, 6125–6135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6763180</ArticleId>
            <ArticleId IdType="pubmed">11487636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honore N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG, 2001. Massive gene decay in the leprosy bacillus. Nature
409, 1007–1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11234002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dastur DK, 1955. Cutaneous nerves in leprosy; the relationship between histopathology and cutaneous sensibility. Brain
78, 615–633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13293272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diamond J, Holmes M, Coughlin M, 1992. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci
12, 1454–1466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6575805</ArticleId>
            <ArticleId IdType="pubmed">1556603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, Polydefkis M, Maeda Y, Makino M, Truman RW, Reed SG, 2018. LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection. NPJ Vaccines
3, 12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5871809</ArticleId>
            <ArticleId IdType="pubmed">29619252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, Arumugam S, Job CK, 1999. Infection by M. leprae is governed by the temperature at the entry point: a preliminary note. Int J Lepr Other Mycobact Dis
67, 162–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10472370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, Arumugam S, Job CK, 2002. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice. Int J Lepr Other Mycobact Dis
70, 245–249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12768925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, Hauer P, Gibbons C, McArthur JC, Polydefkis M, 2007a. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. Journal of neuropathology and experimental neurology
66, 1059–1073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18090915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, Laast VA, Dearman B, Hauer P, Tarwater PM, Adams RJ, Zink MC, McArthur JC, Mankowski JL, 2009a. Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model. The Journal of comparative neurology
514, 272–283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720153</ArticleId>
            <ArticleId IdType="pubmed">19296476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, Laast VA, Dearman B, Hauer P, Tarwater PM, Adams RJ, Zink MC, McArthur JC, Mankowski JL, 2009b. Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model. The Journal of comparative neurology
514, 272–283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720153</ArticleId>
            <ArticleId IdType="pubmed">19296476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, McArthur JC, Polydefkis M, Dorsey JL, O’Donnell R, Hauer P, Adams RJ, Mankowski JL, 2012. SIV-induced impairment of neurovascular repair: a potential role for VEGF. J Neurovirol
18, 222–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3804009</ArticleId>
            <ArticleId IdType="pubmed">22549763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, McArthur JC, Thomas D, Murinson B, Hauer P, Polydefkis M, Griffin JW, 2007b. Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain
130, 2703–2714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17898011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebenezer GJ, O’Donnell R, Hauer P, Cimino NP, McArthur JC, Polydefkis M, 2011. Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain
134, 1853–1863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3140859</ArticleId>
            <ArticleId IdType="pubmed">21616974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Facer P, Mann D, Mathur R, Pandya S, Ladiwala U, Singhal B, Hongo J, Sinicropi DV, Terenghi G, Anand P, 2000. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy?
Pain
85, 231–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10692623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geluk A, van Meijgaarden KE, Wilson L, Bobosha K, van der Ploeg-van Schip JJ, van den Eeden SJ, Quinten E, Dijkman K, Franken KL, Haisma EM, Haks MC, van Hees CL, Ottenhoff TH, 2014. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions. J Clin Immunol
34, 245–255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24370984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffin JW HA, Nguyen TT, 2006. 
Neural Repair and Plasticity, in: Michael E. Selzer, S.C., Leonardo Cohen, Pamela Duncan, Fred Gage (Ed.), Textbook of Neural Repair and Rehabilitation. Cambridge University Press;  pp. 293–303.</Citation>
        </Reference>
        <Reference>
          <Citation>Griffin JW, Thompson WJ, 2008. Biology and pathology of nonmyelinating Schwann cells. Glia
56, 1518–1531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18803315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagge DA, Oby Robinson S, Scollard D, McCormick G, Williams DL, 2002. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions. The Journal of infectious diseases
186, 1283–1296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12402198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagge DA, Saunders BM, Ebenezer GJ, Ray NA, Marks VT, Britton WJ, Krahenbuhl JL, Adams LB, 2009. Lymphotoxin-α and TNF Have Essential but Independent Roles in the Evolution of the Granulomatous Response in Experimental Leprosy. The American journal of pathology
174, 1379–1389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2671369</ArticleId>
            <ArticleId IdType="pubmed">19246648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagge DA, Scollard DM, Ray NA, Marks VT, Deming AT, Spencer JS, Adams LB, 2014. IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy. PLoS Negl Trop Dis
8, e3149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4161319</ArticleId>
            <ArticleId IdType="pubmed">25210773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn K, Sirdofsky M, Brown A, Ebenezer G, Hauer P, Miller C, Polydefkis M, 2006. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J Peripher Nerv Syst
11, 142–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16787512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hess S, Rambukkana A, 2019. Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System. Microbiol Spectr
7.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoke A, Redett R, Hameed H, Jari R, Zhou C, Li ZB, Griffin JW, Brushart TM, 2006. Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci
26, 9646–9655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6674436</ArticleId>
            <ArticleId IdType="pubmed">16988035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibrahim Z, Ebenezer G, Christensen JM, Sarhane KA, Hauer P, Cooney DS, Sacks JM, Schneeberger S, Lee WP, Polydefkis M, Brandacher G, 2013. Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflaps. PLoS One
8, e77646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3799840</ArticleId>
            <ArticleId IdType="pubmed">24204901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson PC, Diamond J, 1981. Regenerating axons reclaim sensory targets from collateral nerve sprouts. Science (New York, N.Y
214, 926–928.</Citation>
        </Reference>
        <Reference>
          <Citation>Jopling C, Boue S, Izpisua Belmonte JC, 2011. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nature reviews. Molecular cell biology
12, 79–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21252997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT, 2004. 10–12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy. Vaccine
22, 3649–3657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15315844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khoshnoodi MA, Ebenezer GJ, Polydefkis M, 2017. Epidermal innervation as a tool to study human axonal regeneration and disease progression. Experimental neurology
287, 358–364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27317299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehmann HC, Hoke A, 2010. Schwann cells as a therapeutic target for peripheral neuropathies. CNS Neurol Disord Drug Targets
9, 801–806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4053445</ArticleId>
            <ArticleId IdType="pubmed">20874704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewin GR, Mendell LM, 1993. Nerve growth factor and nociception. Trends Neurosci
16, 353–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7694405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lockwood DNJ, 2019. Chronic aspects of leprosy-neglected but important. Trans R Soc Trop Med Hyg
113, 813–817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30715525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loughry WJ, Truman RW, McDonough CM, Tilak MK, Garnier S, Delsuc F, 2009. Is leprosy spreading among nine-banded armadillos in the southeastern United States?
J Wildl Dis
45, 144–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19204343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mangus LM, Rao DB, Ebenezer GJ, 2019. Intraepidermal Nerve Fiber Analysis in Human Patients and Animal Models of Peripheral Neuropathy: A Comparative Review. Toxicologic pathology, 192623319855969.</Citation>
        </Reference>
        <Reference>
          <Citation>Mangus LM, Rao DB, Ebenezer GJ, 2020. Intraepidermal Nerve Fiber Analysis in Human Patients and Animal Models of Peripheral Neuropathy: A Comparative Review. Toxicologic pathology
48, 59–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31221022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, McGlinchey A, Cholewa-Waclaw J, Qu J, Tomlinson SR, Rambukkana A, 2014. Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. Cellular reprogramming
16, 9–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3920758</ArticleId>
            <ArticleId IdType="pubmed">24279882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A, 2013. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell
152, 51–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4314110</ArticleId>
            <ArticleId IdType="pubmed">23332746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matson JP, Cook JG, 2017. Cell cycle proliferation decisions: the impact of single cell analyses. The FEBS journal
284, 362–375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5296213</ArticleId>
            <ArticleId IdType="pubmed">27634578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meima A, van Veen NH, Richardus JH, 2008. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration. Tropical medicine &amp; international health : TM &amp; IH
13, 241–246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18304271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miko TL, Le Maitre C, Kinfu Y, 1993. Damage and regeneration of peripheral nerves in advanced treated leprosy. Lancet
342, 521–525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8102668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mouton PR, Gokhale AM, Ward NL, West MJ, 2002. Stereological length estimation using spherical probes. Journal of microscopy
206, 54–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12000563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nath I, Singh R, 1980. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Clin Exp Immunol
41, 406–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1537043</ArticleId>
            <ArticleId IdType="pubmed">7002396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellegrino RG, Politis MJ, Ritchie JM, Spencer PS, 1986. Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. Journal of neurocytology
15, 17–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3086507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penna GO, Buhrer-Sekula S, Kerr LRS, Stefani MMA, Rodrigues LC, de Araujo MG, Ramos AMC, de Andrade ARC, Costa MB, Rosa PS, Goncalves HS, Cruz R, Barreto ML, Pontes MAA, Penna MLF, 2017. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Negl Trop Dis
11, e0005725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5526599</ArticleId>
            <ArticleId IdType="pubmed">28704363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajan B, Polydefkis M, Hauer P, Griffin JW, McArthur JC, 2003. Epidermal reinnervation after intracutaneous axotomy in man. The Journal of comparative neurology
457, 24–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12541322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A, 2010. Usage of signaling in neurodegeneration and regeneration of peripheral nerves by leprosy bacteria. Progress in neurobiology
91, 102–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20005916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardus JH, Habbema JD, 2007. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
Leprosy review
78, 330–337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18309706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardus JH, Nicholls PG, Croft RP, Withington SG, Smith WC, 2004. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. Int J Epidemiol
33, 337–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15082636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosa PS, D’Espindula HRS, Melo ACL, Fontes ANB, Finardi AJ, Belone AFF, Sartori BGC, Pires CAA, Soares CT, Marques FB, Branco FJD, Baptista I, Trino LM, Fachin LRV, Xavier MB, Floriano MC, Ura S, Diorio SM, Delanina WFB, Moraes MO, Virmond MCL, Suffys PN, Mira MT, 2019. Emergence and transmission of drug/multidrug-resistant Mycobacterium leprae in a former leprosy colony in the Brazilian Amazon. Clin Infect Dis.</Citation>
        </Reference>
        <Reference>
          <Citation>Sabin TD, 1969. Temperature-linked sensory loss. A unique pattern in leprosy. Archives of neurology
20, 257–262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5766490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schreuder PA, Noto S, Richardus JH, 2016. Epidemiologic trends of leprosy for the 21st century. Clin Dermatol
34, 24–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26773620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scollard DM, 2008. The biology of nerve injury in leprosy. Leprosy review
79, 242–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19009974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL, 2006. The continuing challenges of leprosy. Clin Microbiol Rev
19, 338–381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1471987</ArticleId>
            <ArticleId IdType="pubmed">16614253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scollard DM, Truman RW, Ebenezer GJ, 2015. Mechanisms of nerve injury in leprosy. Clin Dermatol
33, 46–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25432810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma R, Lahiri R, Scollard DM, Pena M, Williams DL, Adams LB, Figarola J, Truman RW, 2013. The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases. Disease models &amp; mechanisms
6, 19–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3529335</ArticleId>
            <ArticleId IdType="pubmed">23223615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song XY, Zhou FH, Zhong JH, Wu LL, Zhou XF, 2006. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. Journal of neurochemistry
96, 833–842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16336221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spierings E, De Boer T, Zulianello L, Ottenhoff TH, 2000. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae. Immunol Cell Biol
78, 349–355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10947859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stefani MMA, Avanzi C, Buhrer-Sekula S, Benjak A, Loiseau C, Singh P, Pontes MAA, Goncalves HS, Hungria EM, Busso P, Piton J, Silveira MIS, Cruz R, Schetinni A, Costa MB, Virmond MCL, Diorio SM, Dias-Baptista IMF, Rosa PS, Matsuoka M, Penna MLF, Cole ST, Penna GO, 2017. Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases. PLoS Negl Trop Dis
11, e0005598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5498066</ArticleId>
            <ArticleId IdType="pubmed">28617800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storrs EE, Walsh GP, Burchfield HP, Binford CH, 1974. Leprosy in the armadillo: new model for biomedical research. Science (New York, N.Y
183, 851–852.</Citation>
        </Reference>
        <Reference>
          <Citation>Sulaiman OA, Gordon T, 2000. Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia
32, 234–246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11102965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sulaiman OA, Midha R, Munro CA, Matsuyama T, Al-Majed A, Gordon T, 2002. Chronic Schwann cell denervation and the presence of a sensory nerve reduce motor axonal regeneration. Experimental neurology
176, 342–354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12359176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi M, Matsuzaki S, Tohyama M, 2007. P75 plays a key role in the induction of the sprouting of sensory nerve fibers in inflamed skin. The Journal of investigative dermatology
127, 2062–2065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17410199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truman RW, Ebenezer GJ, Pena MT, Sharma R, Balamayooran G, Gillingwater TH, Scollard DM, McArthur JC, Rambukkana A, 2014. The armadillo as a model for peripheral neuropathy in leprosy. ILAR journal / National Research Council, Institute of Laboratory Animal Resources
54, 304–314.</Citation>
        </Reference>
        <Reference>
          <Citation>Vallat JM, Leboutet MJ, Henry P, Millan J, Dumas M, 1991. Endoneurial proliferation of perineurial cells in leprosy. Acta Neuropathol
81, 336–338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1711759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdu E, Ceballos D, Vilches JJ, Navarro X, 2000. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst
5, 191–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11151980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wegner M, 2013. Mighty bugs: leprosy bacteria turn schwann cells into stem cells. Cell
152, 15–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23332743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West MJ, Slomianka L, Gundersen HJ, 1991. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. The Anatomical record
231, 482–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1793176</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
